NKGN

0.00300.00%
YM

Yong Man Kim

Chief Scientific Officer

Dr. Yong Man Kim, PhD serves as Chief Technical Officer at NKGen Biotech Korea Co., Ltd. (formerly known as NKMAX CO., Ltd.) and serves as Chief Operating Officer since October 2024. Dr. Kim is Chief Scientific Officer at NKGen Biotech, Inc. since September 2023. Dr. Kim served as Chief Scientific Officer of Legacy NKGen from January 2020 to September 2023 and a director of Legacy NKGen from November 2021 to September 2023. He has extensive experience in the industry of cellular therapeutics. Prior to working for NKGen Biotech, he served as the GMP and R&D Center Director for Pharmicell Co., Ltd, a well-known Korean Stem Cell Biopharmaceutical Company, where he successfully obtained the first stem cell therapy KFDA approval in Korea. Prior to working in the Industry, Dr. Kim was a research Professor at Wonkwang University School of Medicine. He has been a visiting Fellow for the Genetic Pharmacology Unit in NINDS, the Neurobiological branch of the National Institute of Health. He had his Post-Doc. at the Department of Immunology at the Korea Research Institute of Bioscience and Biotechnology. He earned his PhD in Cell Biology from Chungnam National University in Korea.

Positions